Vedbæk, Denmark

Niels Skjaerback

This inventor holds 1 USPTO granted patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niels Skjaerback. Retrieved from https://idiyas.com/inventor/niels-skjaerback

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niels Skjaerback: Innovator in Muscarinic Agonists

Introduction

Niels Skjaerback is a notable inventor based in Vedbaek, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of muscarinic receptor agonists. His innovative work has the potential to impact various therapeutic areas.

Latest Patents

Niels Skjaerback holds a patent for "Tetrahydroquinoline analogues as muscarinic agonists." This invention relates to tetrahydroquinoline compounds that act as muscarinic receptor agonists. The patent includes compositions comprising these compounds, methods for inhibiting muscarinic receptor activity, and approaches for treating diseases associated with muscarinic receptors. Additionally, it outlines methods for identifying suitable subjects for treatment using these compounds. He has 1 patent to his name.

Career Highlights

Niels Skjaerback is currently associated with Acadia Pharmaceuticals Inc., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that address unmet medical needs.

Collaborations

Throughout his career, Niels has collaborated with esteemed colleagues, including Kristian Norup Koch and Bo Lennart Mikael Friberg. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Niels Skjaerback is a prominent figure in the field of pharmacology, with a focus on muscarinic receptor agonists. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for future innovations in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…